IV

Inglewood Ventures

North America, California, United States, San Diego

Description

Inglewood Ventures is a venture capital firm specializing in early stage companies.

Investor Profile

Inglewood Ventures has made 10 investments, with 0 in the past 12 months and 30% as lead.

Stage Focus

  • Series Unknown (30%)
  • Series C (20%)
  • Series D (20%)
  • Series B (10%)
  • Series A (10%)
  • Series E (10%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Biotechnology
  • Therapeutics
  • Medical
  • Medical Device
  • Pharmaceutical
  • Advanced Materials
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Inglewood Ventures frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 2
BP
North America, California, United States, San Diego
Co-Investments: 1
PB
North America, New York, United States, New York
Co-Investments: 2
Sanderling Ventures
North America, California, United States, San Mateo
Co-Investments: 3
Burrill & Company
North America, California, United States, San Francisco
Co-Investments: 2
ML
North America, New York, United States, New York
Co-Investments: 2
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 3
MF
North America, Wisconsin, United States, Madison
Co-Investments: 2
GeneChem
North America, Quebec, Canada, Montréal
Co-Investments: 4
IDEO
North America, California, United States, Palo Alto
Co-Investments: 1

What are some of recent deals done by Inglewood Ventures?

NewBiotics

San Diego, California, United States

NewBiotics' strategy is to transform drug resistance into therapeutic advantage.

Health CareMedicalTherapeutics
Series EApr 27, 2004
Amount Raised: $4,570,000
CardioNet

Conshohocken, Pennsylvania, United States

CardioNet provides real-time ambulatory outpatient management solutions to monitor clinical information of people.

BiotechnologyHealth CareMedical Device
Series DMar 1, 2004
Amount Raised: $10,000,000
Conforma Therapeutics

San Diego, California, United States

Conforma Therapeutics Corporation designs and develops drugs for the treatment of cancer.

Health CareTherapeutics
Series CSep 18, 2003
Amount Raised: $30,000,000
Cylene Pharmaceuticals

San Diego, California, United States

Cylene Pharmaceuticals discovers, develops and commercializes small molecule drugs that target nucleolus and kill cancer cells.

BiotechnologyHealth CarePharmaceutical
Series AOct 17, 2001
Amount Raised: $3,500,000
GeneFormatics

San Diego, California, United States

GeneFormatics is a biotechnology company specializing in structural proteomics.

Biotechnology
Series UnknownOct 17, 2001
Amount Raised: $22,000,000
NewBiotics

San Diego, California, United States

NewBiotics' strategy is to transform drug resistance into therapeutic advantage.

Health CareMedicalTherapeutics
Series CJul 25, 2001
Amount Raised: $11,000,000
Genicon Sciences

San Diego, California, United States

Genicon Sciences is focused on the development, manufacture and distribution of bioassay products & services to the all lifesciences market.

Advanced Materials
Series DJun 6, 2001
Amount Raised: $32,000,000
GeneFormatics

San Diego, California, United States

GeneFormatics is a biotechnology company specializing in structural proteomics.

Biotechnology
Series UnknownOct 5, 2000
Amount Raised: $15,000,000
CardioNet

Conshohocken, Pennsylvania, United States

CardioNet provides real-time ambulatory outpatient management solutions to monitor clinical information of people.

BiotechnologyHealth CareMedical Device
Series BMay 1, 2000
Amount Raised: $6,900,000
NewBiotics

San Diego, California, United States

NewBiotics' strategy is to transform drug resistance into therapeutic advantage.

Health CareMedicalTherapeutics
Series UnknownApr 4, 2000
Amount Raised: $6,300,000